+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Intelligence in Mental Health Market Size, Share - Growth Analysis Report and Forecast Trends (2026-2035)

  • PDF Icon

    Report

  • 400 Pages
  • May 2026
  • Region: Global
  • Expert Market Research
  • ID: 6253079
The global artificial intelligence (AI) in mental health market was valued at USD 1.70 Billion in 2025. It is poised to grow at a CAGR of 17.30% during the forecast period of 2026-2035, and reach USD 8.38 Billion by 2035. The market growth is driven by the rising mental health disorders, increasing adoption of digital therapeutics, and advancements in AI technologies, driving market growth, supported by demand for treatment planning AI to enhance personalized care and clinical efficiency.

Key Market Trends and Insights

  • By technology, the machine learning segment dominated the market, capturing a above 47% share during the historical period.
  • The software segment led the artificial intelligence in the mental health industry, accounting for the largest revenue share of approximately 75% during the historical period.
  • The North America regional market accounted for the largest revenue share of over 33% during the historical period.

Market Size and Forecast

  • Market Size (2025): USD 1.70 Billion
  • Projected Market Size (2035): USD 8.38 Billion
  • CAGR (2026-2035): 17.30%

Artificial Intelligence in Mental Health Market Overview

Artificial Intelligence (AI) is transforming mental health care by enabling early detection, continuous monitoring, and personalized interventions. AI-powered chatbots and virtual therapists provide scalable support, while analytics improve diagnosis and care pathways. Advanced tools using cancer prognosis prediction-like modeling approaches help forecast patient outcomes, optimize treatment strategies, and enhance clinical decision-making, improving accessibility, efficiency, and overall treatment effectiveness across healthcare systems. The market reached a value of approximately USD 1.70 Billion in 2025.

Artificial Intelligence in Mental Health Market Growth Drivers

Rising Global Burden Accelerating the Market Demand

The growing burden of mental health disorders is driving urgent demand for innovative and scalable treatment solutions. Globally, more than 1 billion people are living with mental health disorders, including anxiety and depression, making them a leading cause of disability worldwide. This growing burden underscores the critical need for scalable, technology-driven interventions such as AI-enabled mental health solutions to improve access, early detection, and treatment outcomes.

Artificial Intelligence in Mental Health Market Trends

Key trends shaping the market include regulatory advancements, clinical validation, and adoption of treatment planning AI solutions.

Regulatory Evolution Shaping AI-Based Mental Health Treatment

The market is witnessing a shift toward regulated adoption of AI-driven mental health treatments, as agencies like the FDA and CMS establish frameworks for generative AI-enabled devices. In November 2025, the U.S. Food and Drug Administration convened its Digital Health Advisory Committee to evaluate generative AI-enabled mental health devices, emphasizing their role in diagnosis and treatment alongside safety and clinical validation requirements. This development highlights a broader industry shift toward regulated deployment of AI solutions, encouraging innovation while ensuring compliance. Such initiatives are accelerating the adoption of treatment planning AI, supporting structured integration into clinical mental healthcare systems.

Artificial Intelligence in Mental Health Market Segmentation

Market Breakup by Offering

  • Solutions
  • Chatbots and Virtual Therapist
  • Monitoring and Diagnostics Tools
  • Personalized Treatment Solutions
  • Others
  • Services
  • Professional Services
  • Managed Services

Market Breakup by Technology

  • Machine Learning
  • Natural Language Processing
  • Deep Learning
  • Speech Recognition
  • Others

Market Breakup by Application

  • Depression
  • Anxiety Disorders
  • Post-Traumatic Stress Disorder (PTSD)
  • Schizophrenia
  • Eating Disorders
  • Others

Market Breakup by End-User

  • Healthcare Providers
  • Payers and Insurance Companies
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Artificial Intelligence in Mental Health Market Share

Machine Learning Expected to Dominate the Market Share by Technology

By technology, the machine learning segment accounted for the highest market share of around 47% during the historical period, driven by its ability to enhance predictive analytics and automate clinical decision-making. Its growing adoption in drug response prediction applications supports personalized therapy recommendations and improves patient outcomes. Increasing integration of machine learning with digital therapeutics and mental health platforms is further strengthening its dominance across global healthcare ecosystems.

Artificial Intelligence in Mental Health Market Analysis by Region

North America held the largest revenue share of above 33% during the historical period, supported by advanced healthcare infrastructure and early adoption of digital health technologies. The region is witnessing strong implementation of clinical trial matching tools, enabling efficient patient recruitment and improved research outcomes. Favorable regulatory frameworks, rising mental health awareness, and significant investments in AI startups continue to drive regional market growth.

Leading Players in the Artificial Intelligence in Mental Health Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:

Wysa Ltd

Wysa Ltd is a London-headquartered digital mental health company founded in 2015. It offers an AI-powered chatbot, coaching tools, and clinical support platforms such as Wysa Copilot. The company leverages real-world data oncology-like analytics approaches in healthcare AI to improve personalized interventions and patient engagement across employers and healthcare systems globally.

Woebot Health

Woebot Health, founded in 2017 and headquartered in San Francisco, develops AI-driven conversational agents for mental health support. Its portfolio includes Woebot Companion and provider-focused tools designed for scalable care delivery. The company’s platform reflects principles similar to treatment planning AI, enhancing clinical workflows and enabling personalized, evidence-based therapeutic interactions.

Limbic

Limbic is a London-based health-tech company established in 2018. It specializes in clinical AI solutions such as Limbic Access and Limbic Care, supporting patient triage and therapy. Its technology aligns with tumor board AI-like decision-support frameworks by assisting clinicians in diagnosis, triaging, and optimizing treatment pathways in complex healthcare environments.

Youper Inc.

Youper Inc., founded in 2016 and headquartered in San Francisco, provides AI-driven mental health solutions through an emotional health assistant. Its platform integrates behavioral therapy, monitoring, and personalized care delivery. The company utilizes approaches comparable to survival analysis in predictive healthcare modeling to improve patient outcomes and long-term mental health management.

Other key players in the market are Eleos Health Inc., among others.

Key Questions Answered in the Artificial Intelligence in Mental Health Market

  • What was the artificial intelligence in mental health market value in 2025?
  • What is the artificial intelligence in mental health market forecast outlook for 2026-2035?
  • What major factors aid the demand for artificial intelligence in mental health market?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market’s major drivers, opportunities, and restraints?
  • What are the major artificial intelligence in mental health market trends?
  • Which offering is expected to dominate the market segment?
  • Which technology is projected to lead the market segment?
  • Which application is likely to dominate the market segment?
  • Which end user is expected to dominate the market segment?
  • Who are the key players in the artificial intelligence in mental health market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Artificial Intelligence in Mental Health Market Overview
3.1 Global Artificial Intelligence in Mental Health Market Overview
3.1.1 Global Artificial Intelligence in Mental Health Market Historical Value (2019-2025)
3.1.2 Global Artificial Intelligence in Mental Health Market Forecast Value (2026-2035)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Artificial Intelligence in Mental Health Market Landscape
5.1 Global Artificial Intelligence in Mental Health Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Artificial Intelligence in Mental Health Market: Product Landscape
5.2.1 Analysis By Offering
5.2.2 Analysis By Technology
5.2.3 Analysis By Application
6 Global Artificial Intelligence in Mental Health Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Artificial Intelligence in Mental Health Market Segmentation (219-2035)
7.1 Global Artificial Intelligence in Mental Health Market (2019-2035) by Offering
7.1.1 Market Overview
7.1.2 Solutions
7.1.2.1 Chatbots & Virtual Therapist
7.1.2.2 Monitoring and Diagnostics Tools
7.1.2.3 Personalized Treatment Solutions
7.1.2.4 Others
7.1.3 Services
7.1.3.1 Professional Services
7.1.3.2 Managed Services
7.2 Global Artificial Intelligence in Mental Health Market (2019-2035) by Technology
7.2.1 Market Overview
7.2.2 Machine Learning
7.2.3 Natural Language Processing
7.2.4 Deep Learning
7.2.5 Speech Recognition
7.2.6 Others
7.3 Global Artificial Intelligence in Mental Health Market (2019-2035) by Application
7.3.1 Market Overview
7.3.2 Depression
7.3.3 Anxiety Disorders
7.3.4 Post-Traumatic Stress Disorder (PTSD)
7.3.5 Schizophrenia
7.3.6 Eating Disorders
7.3.7 Others
7.4 Global Artificial Intelligence in Mental Health Market (2019-2035) by End User
7.4.1 Market Overview
7.4.2 Healthcare Providers
7.4.3 Payers & Insurance Companies
7.4.4 Others
7.5 Global Artificial Intelligence in Mental Health Market (2019-2035) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East & Africa
8 North America Artificial Intelligence in Mental Health Market Segmentation (219-2035)
8.1 North America Artificial Intelligence in Mental Health Market (2019-2035) by Offering
8.1.1 Market Overview
8.1.2 Solutions
8.1.2.1 Chatbots & Virtual Therapist
8.1.2.2 Monitoring and Diagnostics Tools
8.1.2.3 Personalized Treatment Solutions
8.1.2.4 Others
8.1.3 Services
8.1.3.1 Professional Services
8.1.3.2 Managed Services
8.2 North America Artificial Intelligence in Mental Health Market (2019-2035) by Technology
8.2.1 Market Overview
8.2.2 Machine Learning
8.2.3 Natural Language Processing
8.2.4 Deep Learning
8.2.5 Speech Recognition
8.2.6 Others
8.3 North America Artificial Intelligence in Mental Health Market (2019-2035) by Application
8.3.1 Market Overview
8.3.2 Depression
8.3.3 Anxiety Disorders
8.3.4 Post-Traumatic Stress Disorder (PTSD)
8.3.5 Schizophrenia
8.3.6 Eating Disorders
8.3.7 Others
8.4 North America Artificial Intelligence in Mental Health Market (2019-2035) by End User
8.4.1 Market Overview
8.4.2 Healthcare Providers
8.4.3 Payers & Insurance Companies
8.4.4 Others
8.5 North America Artificial Intelligence in Mental Health Market (2019-2035) by Region
8.5.1 Market Overview
8.5.2 United States
8.5.3 Canada
9 Europe Artificial Intelligence in Mental Health Market Segmentation (219-2035)
9.1 Europe Artificial Intelligence in Mental Health Market (2019-2035) by Offering
9.1.1 Market Overview
9.1.2 Solutions
9.1.2.1 Chatbots & Virtual Therapist
9.1.2.2 Monitoring and Diagnostics Tools
9.1.2.3 Personalized Treatment Solutions
9.1.2.4 Others
9.1.3 Services
9.1.3.1 Professional Services
9.1.3.2 Managed Services
9.2 Europe Artificial Intelligence in Mental Health Market (2019-2035) by Technology
9.2.1 Market Overview
9.2.2 Machine Learning
9.2.3 Natural Language Processing
9.2.4 Deep Learning
9.2.5 Speech Recognition
9.2.6 Others
9.3 Europe Artificial Intelligence in Mental Health Market (2019-2035) by Application
9.3.1 Market Overview
9.3.2 Depression
9.3.3 Anxiety Disorders
9.3.4 Post-Traumatic Stress Disorder (PTSD)
9.3.5 Schizophrenia
9.3.6 Eating Disorders
9.3.7 Others
9.4 Europe Artificial Intelligence in Mental Health Market (2019-2035) by End User
9.4.1 Market Overview
9.4.2 Healthcare Providers
9.4.3 Payers & Insurance Companies
9.4.4 Others
9.5 Europe Artificial Intelligence in Mental Health Market (2019-2035) by Region
9.5.1 Market Overview
9.5.2 United Kingdom
9.5.3 Germany
9.5.4 France
9.5.5 Italy
9.5.6 Spain
9.5.7 Others
10 Asia Pacific Artificial Intelligence in Mental Health Market Segmentation (219-2035)
10.1 Asia Pacific Artificial Intelligence in Mental Health Market (2019-2035) by Offering
10.1.1 Market Overview
10.1.2 Solutions
10.1.2.1 Chatbots & Virtual Therapist
10.1.2.2 Monitoring and Diagnostics Tools
10.1.2.3 Personalized Treatment Solutions
10.1.2.4 Others
10.1.3 Services
10.1.3.1 Professional Services
10.1.3.2 Managed Services
10.2 Asia Pacific Artificial Intelligence in Mental Health Market (2019-2035) by Technology
10.2.1 Market Overview
10.2.2 Machine Learning
10.2.3 Natural Language Processing
10.2.4 Deep Learning
10.2.5 Speech Recognition
10.2.6 Others
10.3 Asia Pacific Artificial Intelligence in Mental Health Market (2019-2035) by Application
10.3.1 Market Overview
10.3.2 Depression
10.3.3 Anxiety Disorders
10.3.4 Post-Traumatic Stress Disorder (PTSD)
10.3.5 Schizophrenia
10.3.6 Eating Disorders
10.3.7 Others
10.4 Asia Pacific Artificial Intelligence in Mental Health Market (2019-2035) by End User
10.4.1 Market Overview
10.4.2 Healthcare Providers
10.4.3 Payers & Insurance Companies
10.4.4 Others
10.5 Asia Pacific Artificial Intelligence in Mental Health Market (2019-2035) by Region
10.5.1 Market Overview
10.5.2 China
10.5.3 Japan
10.5.4 India
10.5.5 ASEAN
10.5.6 Australia
10.5.7 Others
11 Latin America Artificial Intelligence in Mental Health Market Segmentation (219-2035)
11.1 Latin America Artificial Intelligence in Mental Health Market (2019-2035) by Offering
11.1.1 Market Overview
11.1.2 Solutions
11.1.2.1 Chatbots & Virtual Therapist
11.1.2.2 Monitoring and Diagnostics Tools
11.1.2.3 Personalized Treatment Solutions
11.1.2.4 Others
11.1.3 Services
11.1.3.1 Professional Services
11.1.3.2 Managed Services
11.2 Latin America Artificial Intelligence in Mental Health Market (2019-2035) by Technology
11.2.1 Market Overview
11.2.2 Machine Learning
11.2.3 Natural Language Processing
11.2.4 Deep Learning
11.2.5 Speech Recognition
11.2.6 Others
11.3 Latin America Artificial Intelligence in Mental Health Market (2019-2035) by Application
11.3.1 Market Overview
11.3.2 Depression
11.3.3 Anxiety Disorders
11.3.4 Post-Traumatic Stress Disorder (PTSD)
11.3.5 Schizophrenia
11.3.6 Eating Disorders
11.3.7 Others
11.4 Latin America Artificial Intelligence in Mental Health Market (2019-2035) by End User
11.4.1 Market Overview
11.4.2 Healthcare Providers
11.4.3 Payers & Insurance Companies
11.4.4 Others
11.5 Latin America Artificial Intelligence in Mental Health Market (2019-2035) by Region
11.5.1 Market Overview
11.5.2 Brazil
11.5.3 Mexico
11.5.4 Argentina
11.5.5 Others
12 Middle East & Africa Artificial Intelligence in Mental Health Market Segmentation (219-2035)
12.1 Middle East & Africa Artificial Intelligence in Mental Health Market (2019-2035) by Offering
12.1.1 Market Overview
12.1.2 Solutions
12.1.2.1 Chatbots & Virtual Therapist
12.1.2.2 Monitoring and Diagnostics Tools
12.1.2.3 Personalized Treatment Solutions
12.1.2.4 Others
12.1.3 Services
12.1.3.1 Professional Services
12.1.3.2 Managed Services
12.2 Middle East & Africa Artificial Intelligence in Mental Health Market (2019-2035) by Technology
12.2.1 Market Overview
12.2.2 Machine Learning
12.2.3 Natural Language Processing
12.2.4 Deep Learning
12.2.5 Speech Recognition
12.2.6 Others
12.3 Middle East & Africa Artificial Intelligence in Mental Health Market (2019-2035) by Application
12.3.1 Market Overview
12.3.2 Depression
12.3.3 Anxiety Disorders
12.3.4 Post-Traumatic Stress Disorder (PTSD)
12.3.5 Schizophrenia
12.3.6 Eating Disorders
12.3.7 Others
12.4 Middle East & Africa Artificial Intelligence in Mental Health Market (2019-2035) by End User
12.4.1 Market Overview
12.4.2 Healthcare Providers
12.4.3 Payers & Insurance Companies
12.4.4 Others
12.5 Middle East & Africa Artificial Intelligence in Mental Health Market (2019-2035) by Region
12.5.1 Market Overview
12.5.2 Saudi Arabia
12.5.3 UAE
12.5.4 Nigeria
12.5.5 South Africa
12.5.6 Others
13 Regulatory Framework
14 Patent Analysis
14.1 Analysis By Technology
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Codes
14.6 Analysis by Patent Valuation
15 Grants Analysis
15.1 Analysis by Year
15.2 Analysis by Amount Awarded
15.3 Analysis by Issuing Authority
15.4 Analysis by Grant Application
15.5 Analysis by Funding Institute
15.6 Analysis by NIH Departments
15.7 Analysis by Recipient Organization
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Initiatives
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (Top 5 Companies)
18.2 Wysa Ltd.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Developments
18.2.5 Certifications
18.3 Woebot Health
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Developments
18.3.5 Certifications
18.4 Limbic
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Developments
18.4.5 Certifications
18.5 Youper Inc.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Developments
18.5.5 Certifications
18.6 Eleos Health Inc.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Developments
18.6.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Wysa Ltd
  • Woebot Health
  • Limbic
  • Youper Inc.